NeoGenomics
284 hedge funds and large institutions have $1.48B invested in NeoGenomics in 2023 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 74 increasing their positions, 104 reducing their positions, and 21 closing their positions.
90% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 21
43% more call options, than puts
Call options by funds: $9.75M | Put options by funds: $6.82M
6% more funds holding
Funds holding: 267 → 284 (+17)
2.36% more ownership
Funds ownership: 91.99% → 94.35% (+2.4%)
21% less capital invested
Capital invested by funds: $1.89B → $1.48B (-$404M)
29% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 104
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Top Buyers
| 1 |
Brown Advisory
Baltimore,
Maryland
|
+$24.6M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$11.1M |
| 3 |
GF
Greenhouse Funds
Baltimore,
Maryland
|
+$10.2M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$7.87M |
| 5 |
Jennison Associates
New York
|
+$7.47M |
Top Sellers
| 1 |
BlackRock
New York
|
-$10M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$6.17M |
| 3 |
LCG
Lisanti Capital Growth
New York
|
-$5.4M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$5.25M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.83M |
NEO Hedge Fund Activity: Q3 2023 in Review
284 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q3 2023, worth a combined $1.48B — down 21% from $1.89B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new NEO positions and 21 closed out — a net gain of 19 holders — while 74 added to existing stakes and 104 trimmed.
The largest buyer was Brown Advisory, adding an estimated $24.6M. The largest seller was BlackRock, cutting an estimated $10M.
- 284 institutional investors held NeoGenomics (NEO) as of Q3 2023, up from 267 in Q2 2023.
- Funds reported $1.48B of NeoGenomics stock for Q3 2023, down 21% quarter-over-quarter.
- 40 funds opened new NeoGenomics positions in Q3 2023 and 21 closed out, a net change of +19 holders.
- The largest NeoGenomics buyer in Q3 2023 was Brown Advisory, an estimated $24.6M added.
- The largest NeoGenomics seller in Q3 2023 was BlackRock, an estimated $10M sold.
Based on aggregated 13F filings for Q3 2023.